These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Assessment of acute toxicities and early local recurrences in post mastectomy breast cancer patients by accelerated hypofractionated radiotherapy; a single arm clinical trial. Vijayaraghavan N, Vedasoundaram P, M Mathew J, Menon A, Kannan B. J BUON; 2020; 25(5):2265-2270. PubMed ID: 33277844 [Abstract] [Full Text] [Related]
29. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer. Yu E, Huang D, Leonard K, Dipetrillo T, Wazer D, Hepel J. Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952 [Abstract] [Full Text] [Related]
30. Dose to organs in the supraclavicular region when covering the Internal Mammary Nodes (IMNs) in breast cancer patients: A comparison of Volumetric Modulated Arc Therapy (VMAT) versus 3D and VMAT. Dumane VA, Bakst R, Green S. PLoS One; 2018 Dec; 13(10):e0205770. PubMed ID: 30339705 [Abstract] [Full Text] [Related]
40. A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects. Guenzi M, Vagge S, Azinwi NC, D'Alonzo A, Belgioia L, Garelli S, Gusinu M, Corvò R. Radiat Oncol; 2010 Nov 22; 5():111. PubMed ID: 21092219 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]